Understanding the causes of persistent microalbuminuria in Nigeria
Etiology of Persistent Microalbuminuria in Nigeria
This study is looking at why some people with HIV have a condition called microalbuminuria, which can be an early sign of kidney problems, and it aims to find out how different treatments and infections might affect this, so we can help catch and manage kidney issues earlier for patients in Nigeria.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10836995 on NIH RePORTER |
What this research studies
This research investigates the causes of persistent microalbuminuria, a condition that can indicate early kidney damage and is particularly relevant for individuals living with HIV. The study will analyze the albumin-to-creatinine ratio in patients to identify risk factors associated with microalbuminuria, including the impact of antiretroviral therapy and co-infections. By examining these factors in a Nigerian population, the research aims to improve early detection and management of kidney disease. Patients will be monitored over time to assess changes in their kidney function and overall health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults living with HIV who are receiving antiretroviral therapy and may be at risk for kidney disease.
Not a fit: Patients who are not living with HIV or who do not have microalbuminuria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening and treatment strategies for kidney disease in individuals living with HIV.
How similar studies have performed: Previous research has shown that monitoring microalbuminuria can be effective in predicting kidney disease and cardiovascular risks, suggesting that this approach has potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Wester, C. William — Vanderbilt University Medical Center
- Study coordinator: Wester, C. William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.